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demographic proﬁle and clinical aspects of PNL at our cen-
ter.
Methods: Retrospective analysis of conﬁrmed PNL regis-
tered in leprosy clinic in our institute between January 2003
and July 2007 was undertaken. Demographic and clinical
proﬁle including onset of disease and presenting complaints,
pattern of nerve involvement, presence of nerve abscess and
deformities were analyzed. Investigations such as slit-skin
smear (SSS), skin biopsy, electrophysiological study (EPS)
and nerve biopsy were done.
Results: Of 1975 leprosy cases seen during this period,
188 (9.5%) had PNL which included 160 (85%) males and
28 (15%) females, with 121 (64.36%) cases within 20—40
years. Presenting symptoms were paresthesia, pain, sen-
sory loss and motor weakness. Majority of the patients i.e
119 (63.3%) had 2—5 nerve involvement while 49 (26%) had
>5 nerve involvement. Ulnar nerve was most commonly
involved in 130 (69.14%) cases followed by common per-
oneal in 91 (48.4%). Deformities included claw hand in 50
(26.6%), foot drop in 21 (11.17%) facial palsy in 2 and wrist
drop in one patient only. Skin biopsies were non-speciﬁc in
all cases. Nerve biopsy (n = 17) revealed features ranging
from normal, to inﬁltration with epithelioid cell granulo-
mas, ﬁbrosis, lymphohistiocytic inﬁltrate and AFB positive
foamy histiocytes. EPS showed features of sensory/motor
axonal neuropathy, demyelination, denervation with poor
to moderate renervation or decreased sensory nerve action
potential.
Conclusions: PNL is a distinct type of leprosy in India. Men
are more commonly affected and ulnar nerve involvement
is the most common manifestation. Sensory complaints are
early and more common. Early diagnosis and treatment is
helpful in preventing sequel due to nerve damage.
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Brucellar Epididymo-Orchitis: Review of 45 Cases in Babol
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Infectious Diseases Research Center,Yahyanejad Hospi-
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of)
Background: Brucellar epididymo-orchitis is frequently
seen in endemic regions of brucellosis. The purpose of this
study was to assess the clinical manifestations and outcome
of treatment on 45 cases of brucellar epididymo-orchitis.
Methods: From September 2000 to September 2007, 45
cases of epididymo- orchitis were treated and followed at
the Research Center of Infectious Diseases of Babol Medical
University in north of Iran. The clinical manifestations and
outcome of treatment were recorded.
Results: The mean age of the patients was 32.5± 14
years. The mean duration of the onset of disease to diagno-
sis was 21.5± 12 days. Simultaneous involvements of other
organs were seen in 19 (42.2%) cases. Thirteen cases (28.8%)
were treated by co-trimaxazole + rifampin for two months
and relapse was seen in 1 (7.7%) case and orchitectomy was
performed in 2 (15.4%) cases due to destruction of the testis.
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hirteen cases were treated by co-trimaxazole + doxycycline
or two months and relapse was seen in 1 (7.7%) case. Nine-
een cases were treated by gentamycin for seven days and
oxycycline for 45 days and relapse was seen in 1 (5.3%)
ase. The efﬁcacy of gentamicin plus doxycycline (94.7%)
r cotrimoxazole plus doxycycline (92.3%) were higher than
otrimoazole plus rifampin (76.9%) (p < 0.05).
Conclusion: The results of this study show that simul-
aneous involvement of other organs are frequently seen
n subjects with epididymo-orchitis.Treatment with gen-
amicin plus doxycycline or cotrimoxazole plus doxycycline
oth are recommended for therapy of brucellar epididymo-
rchitis.
oi:10.1016/j.ijid.2008.05.027
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he Expanded Access Program to HAART in Chile: Base-
ine Characteristics and Primary Outcomes of Patients
eceiving Treatment, Evaluated Through the Chilean AIDS
ohort (ChiAC)
. Cortes ∗, M. Wolff, C. Beltran, ChiAC
Chilean AIDS Cohort, Santiago, Chile
Background: Chile, a middle-income country with a pop-
lation of 16.2 million, has a HIV prevalence of ≈0.3%
n adults. Since 2001 there is an expanded access pro-
ram (EAP) for HAART that reached 100% coverage in 2003;
round 13,000 patients are under health care, 85% in the
ublic health system (PHS). 70% of the patients under con-
rol required and received treatment, according to the
ational guidelines. Distribution of therapy is centralized
nd each request is reviewed and approved on an individ-
al basis. The system provides for free: HAART, CD4, viral
oad (VL) and genotype tests as well as additional budget
or diagnosis and treatment of AIDS related diseases. The
utcomes of the EAP in the PHS, have been evaluated by
hiAC, which has enrolled almost 95% of patients on HAART
ince 2001.
Methods: ChiAC database was analyzed for baseline (BL)
haracteristics and primary outcomes: mortality, mainte-
ance of initial regimen and AIDS free survival. Descriptive
tatistics was used.
Results: In 3649 treatment nave patients (15% female)
n HAART, with a follow up (f/u) of 9442 patient-years:
L CDC status: A:23%, B:23.6%, C:53.4%; BL CD4 bellow
00 cells/L:83.4% (51% < 100). Most common ﬁrst HAART
egimen was Combivir® plus efavirenz. Less than 10%
eceived protease inhibitors initially.
Outcomes at 3 years of f/u: 57.5% remained on initial
herapy, 20.6% on second HAART, 4.9% had ≥3 HAART reg-
men. Mortality by BL CD4 count: CD4 0—99: 12.5%, CD4
00—199: 3.5%, CD4>200: 3.1%. Change of HAART due to tox-
city: 47%. VL <400 and <80 cps/mL at 3 years were 77.4% and
4.3%, respectively.
Overall survival at 3 and 5 years of HAART was 90.5% and8% respectively; AIDS free survival at 3 and 5 years was 86%
nd 83% respectively.
Conclusions: The EAP to ART in Chile is succeeding in
chieving high viral control and survival of HIV patients.
hese results are comparable to those of high income coun-
